$13.21
- Trading Volume(24h) 18.59% $186,749,360.86
- Circulating Market Cap$1,320,728,249.95 #79
- Fully Diluted Valuation$1,321,112,225.81
- Circulating Supply99,970,935.41 INJ
- Total Supply100,000,000 INJ
- All-time High $52.62 (Mar 14, 2024)
- All-time Low $0.6574 (Nov 04, 2020)
- Contract Address
- Supported Exchanges +27
- Launched Oct 2020
Analytics
Performances
Comparison
Essentials
Details
Team
Milestones
Financials
Fundraising
Tokenomics
Top Holders
Trade
Open Markets
News
Related News
𝕏 Data
Follow Updates
Follow Lists
Performances
Comparison:
1h | 24h | 7d | 30d | 60d | 90d |
0.99% | 3.42% | 8.59% | 1.46% | 2.91% | 26.57% |
Comparison
Details
Injective is an interoperable layer-1 blockchain that powers the next generation of financial applications. Injective uniquely provides plug-and-play financial infrastructure primitives such as high-performance on-chain decentralized trading infrastructure, decentralized bridges, oracles, and multiple composable smart contract layers such as CosmWasm and EVM.
Milestones
2020-07-29
Injective raised $ 2.6 M in Seed round
2020-10
INJ is live for trading
2020-10-20
Injective raised $ 3.6 M in Public Sale round
2021-04-21
Injective raised $ 10 M in OTC round
2021-11-16
2022-08-10
Injective raised $ 40 M in OTC round
2022-09-20
2024-01-02
2024-10-17
2025-06-13
2025-10-02
Tokenomics
Top Holders
Open Markets
--
# | Exchange | Pair | Price | +2% depth | -2% depth | Volume (24h) | volume % |
---|---|---|---|---|---|---|---|
No Data |
𝕏 Follow Updates

𝕏 Follow Lists
$13.21
- Trading Volume(24h) 18.59% $186,749,360.86
- Circulating Market Cap$1,320,728,249.95 #79
- Fully Diluted Valuation$1,321,112,225.81
- Circulating Supply99,970,935.41 INJ
- Total Supply100,000,000 INJ
- All-time High $52.62 (Mar 14, 2024)
- All-time Low $0.6574 (Nov 04, 2020)
- Total Raised $56M
- Contract Address
- Supported Exchanges +27
- Launched Oct 2020

How do you feel about $INJ today?
Total Votes 15592
Bullish
Bearish
How about Injective? Leave your comment below.



Comments are posted by users and do not constitute financial advice